Chai Discovery
AI drug-discovery company building multimodal foundation models and computer-aided design tools for molecular structure prediction and de novo therapeutic design.
$3.8B*192%increase
AI valuation
$0
$1.25B
$2.5B
$3.75B
$5B
$1.3B
Dec 15, 2025
$3.8B
Jul 14, 2026
2026
Financial events
| Date | Event | Type | Figures | Source |
|---|---|---|---|---|
| Jul 14, 2026 | Chai Discovery Series C | Funding round | $400M raised | Chai Discovery |
| Dec 15, 2025 | Chai Discovery Series B | Funding round | $130M raised | Chai Discovery |
| Aug 6, 2025 | Chai Discovery Series A | Funding round | $70M raised | Chai Discovery |
| Sep 9, 2024 | Chai Discovery seed round | Funding round | $30M raised | Chai Discovery |
* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology